156 related articles for article (PubMed ID: 7830060)
1. Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide.
Hillard CJ; Edgemond WS; Campbell WB
J Neurochem; 1995 Feb; 64(2):677-83. PubMed ID: 7830060
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.
Adams IB; Ryan W; Singer M; Thomas BF; Compton DR; Razdan RK; Martin BR
J Pharmacol Exp Ther; 1995 Jun; 273(3):1172-81. PubMed ID: 7791088
[TBL] [Abstract][Full Text] [Related]
3. The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors.
Edgemond WS; Campbell WB; Hillard CJ
Prostaglandins Leukot Essent Fatty Acids; 1995; 52(2-3):83-6. PubMed ID: 7784462
[TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol.
Qureshi J; Saady M; Cardounel A; Kalimi M
Mol Cell Biochem; 1998 Apr; 181(1-2):21-7. PubMed ID: 9562238
[TBL] [Abstract][Full Text] [Related]
5. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain.
Adams IB; Compton DR; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885
[TBL] [Abstract][Full Text] [Related]
6. Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor.
Deutsch DG; Lin S; Hill WA; Morse KL; Salehani D; Arreaza G; Omeir RL; Makriyannis A
Biochem Biophys Res Commun; 1997 Feb; 231(1):217-21. PubMed ID: 9070252
[TBL] [Abstract][Full Text] [Related]
7. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and behavioral evaluation of alkylated anandamide analogs.
Adams IB; Ryan W; Singer M; Razdan RK; Compton DR; Martin BR
Life Sci; 1995; 56(23-24):2041-8. PubMed ID: 7776830
[TBL] [Abstract][Full Text] [Related]
9. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain.
Hillard CJ; Wilkison DM; Edgemond WS; Campbell WB
Biochim Biophys Acta; 1995 Aug; 1257(3):249-56. PubMed ID: 7647100
[TBL] [Abstract][Full Text] [Related]
11. Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response.
De Petrocellis L; Melck D; Bisogno T; Milone A; Di Marzo V
Neuroscience; 1999; 92(1):377-87. PubMed ID: 10392859
[TBL] [Abstract][Full Text] [Related]
12. Effects of anandamide on cannabinoid receptors in rat brain membranes.
Childers SR; Sexton T; Roy MB
Biochem Pharmacol; 1994 Feb; 47(4):711-5. PubMed ID: 8129747
[TBL] [Abstract][Full Text] [Related]
13. Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations.
Pertwee RG; Fernando SR; Griffin G; Abadji V; Makriyannis A
Eur J Pharmacol; 1995 Jan; 272(1):73-8. PubMed ID: 7713152
[TBL] [Abstract][Full Text] [Related]
14. Biochemistry of the endogenous ligands of cannabinoid receptors.
Di Marzo V; Deutsch DG
Neurobiol Dis; 1998 Dec; 5(6 Pt B):386-404. PubMed ID: 9974173
[TBL] [Abstract][Full Text] [Related]
15. Novel analogues of arachidonylethanolamide (anandamide): affinities for the CB1 and CB2 cannabinoid receptors and metabolic stability.
Lin S; Khanolkar AD; Fan P; Goutopoulos A; Qin C; Papahadjis D; Makriyannis A
J Med Chem; 1998 Dec; 41(27):5353-61. PubMed ID: 9876105
[TBL] [Abstract][Full Text] [Related]
16. Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor.
Kimura T; Ohta T; Watanabe K; Yoshimura H; Yamamoto I
Biol Pharm Bull; 1998 Mar; 21(3):224-6. PubMed ID: 9556149
[TBL] [Abstract][Full Text] [Related]
17. Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction.
Felder CC; Briley EM; Axelrod J; Simpson JT; Mackie K; Devane WA
Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7656-60. PubMed ID: 8395053
[TBL] [Abstract][Full Text] [Related]
18. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand.
Goparaju SK; Ueda N; Yamaguchi H; Yamamoto S
FEBS Lett; 1998 Jan; 422(1):69-73. PubMed ID: 9475172
[TBL] [Abstract][Full Text] [Related]
19. Binding of aminoalkylindoles to noncannabinoid binding sites in NG108-15 cells.
Stark S; Pacheco MA; Childers SR
Cell Mol Neurobiol; 1997 Oct; 17(5):483-93. PubMed ID: 9353590
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues.
Stamer WD; Golightly SF; Hosohata Y; Ryan EP; Porter AC; Varga E; Noecker RJ; Felder CC; Yamamura HI
Eur J Pharmacol; 2001 Nov; 431(3):277-86. PubMed ID: 11730719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
